These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5661206)
41. Mycosis fungoides presenting at the site of a transdermal estradiol patch. Alloo A; DeSimone JA; Kupper TS J Am Acad Dermatol; 2012 Nov; 67(5):e207-8. PubMed ID: 23062916 [No Abstract] [Full Text] [Related]
42. A clinical evaluation of a monthly injection for conception control. Keifer WS; Lee AF; Scott JC Am J Obstet Gynecol; 1970 Jun; 107(3):400-10. PubMed ID: 4910699 [No Abstract] [Full Text] [Related]
43. [Use of Depo Provera as a contraceptive in the puerperium]. Narducci U; Piatti N Minerva Ginecol; 1973 Feb; 25(2):107-11. PubMed ID: 4735312 [TBL] [Abstract][Full Text] [Related]
44. Use of injectable contraceptive immediately post partum. Jones JR; Lonky S N Y State J Med; 1971 Oct; 71(19):2279-82. PubMed ID: 5315289 [No Abstract] [Full Text] [Related]
50. [Contraception with the 3-months injection]. Hauser GA Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704 [No Abstract] [Full Text] [Related]
51. [Inhibition of ovulation by a depot injection]. Rodríguez Argüelles J; Ruiz Velasco V Ginecol Obstet Mex; 1969 May; 24(151):471-7. PubMed ID: 5347653 [No Abstract] [Full Text] [Related]
52. Depot estrogen as a monthly contraceptive in nulliparous women with mild uterine hypoplasia. el-Mahgoub S; Karim M Am J Obstet Gynecol; 1972 Feb; 112(4):575-6. PubMed ID: 5008627 [No Abstract] [Full Text] [Related]
53. Current studies in contraception: the use of a long-acting progestogen by injection. Tyler ET S Afr Med J; 1968 Mar; 42(11):257-9. PubMed ID: 4869601 [No Abstract] [Full Text] [Related]
54. [Hormonal induction of lactation in sheep. Effect of a brief treatment]. Manunta G; Marchi S; Nuvole P Boll Soc Ital Biol Sper; 1978 Sep; 54(18):1751-5. PubMed ID: 380597 [No Abstract] [Full Text] [Related]
55. [Use of a new combination: dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17 isobutyrate in gynecology]. Cittadini E; Catalano G Riv Ostet Ginecol Prat Med Perinat; 1973-1974; 54(10):506-12. PubMed ID: 4620236 [No Abstract] [Full Text] [Related]
56. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns. Victor A; Lithell H; Selinus I; Vessby B Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076 [TBL] [Abstract][Full Text] [Related]
57. [Modification of the endometrium during combined therapy with dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17-n-butyrate]. Minucci D; Arreghini G; Rabasso A Riv Ostet Ginecol Prat Med Perinat; 1973-1974; 54(10):497-505. PubMed ID: 4807299 [No Abstract] [Full Text] [Related]
58. [Our experiences with the use of contraceptive preparation Depo-Provera]. Bruchác D; Sklovský A Cesk Gynekol; 1972 Sep; 37(7):516-7. PubMed ID: 4562178 [TBL] [Abstract][Full Text] [Related]